tranexamic acid has been researched along with Cerebral Palsy in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies demonstrated the safety of tranexamic acid (TXA) use in cerebral palsy (CP) patients undergoing proximal femoral varus derotational osteotomy (VDRO), but were underpowered to determine if TXA alters transfusion rates or estimated blood loss (EBL)." | 8.12 | Tranexamic acid use decreases transfusion rate in children with cerebral palsy undergoing proximal femoral varus derotational osteotomy. ( Andras, L; Compton, E; Goldstein, RY; Kay, RM; Nazareth, A; Shymon, SJ, 2022) |
| "Previous studies demonstrated the safety of tranexamic acid (TXA) use in cerebral palsy (CP) patients undergoing proximal femoral varus derotational osteotomy (VDRO), but were underpowered to determine if TXA alters transfusion rates or estimated blood loss (EBL)." | 4.12 | Tranexamic acid use decreases transfusion rate in children with cerebral palsy undergoing proximal femoral varus derotational osteotomy. ( Andras, L; Compton, E; Goldstein, RY; Kay, RM; Nazareth, A; Shymon, SJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Compton, E | 1 |
| Goldstein, RY | 1 |
| Nazareth, A | 1 |
| Shymon, SJ | 1 |
| Andras, L | 1 |
| Kay, RM | 1 |
| Tzatzairis, T | 1 |
| McMahon, S | 1 |
| Shilpa, J | 1 |
| Maizen, C | 1 |
| Masrouha, KZ | 1 |
| Shabin, ZM | 1 |
| Bhutada, K | 1 |
| Sala, DA | 1 |
| Godfried, DH | 1 |
| Karamitopoulos, MS | 1 |
| Dhawale, AA | 1 |
| Shah, SA | 1 |
| Sponseller, PD | 1 |
| Bastrom, T | 1 |
| Neiss, G | 1 |
| Yorgova, P | 1 |
| Newton, PO | 1 |
| Yaszay, B | 1 |
| Abel, MF | 1 |
| Shufflebarger, H | 1 |
| Gabos, PG | 1 |
| Dabney, KW | 1 |
| Miller, F | 1 |
4 other studies available for tranexamic acid and Cerebral Palsy
| Article | Year |
|---|---|
Tranexamic acid use decreases transfusion rate in children with cerebral palsy undergoing proximal femoral varus derotational osteotomy.
Topics: Adolescent; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cerebral Palsy; Child; | 2022 |
Safety and efficacy of tranexamic acid in children with cerebral palsy undergoing femoral varus derotational osteotomy: a double cohort study.
Topics: Adolescent; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cerebral Palsy; Child; | 2020 |
Impact of tranexamic acid on blood loss and transfusion rate in children with cerebral palsy undergoing hip reconstruction with two or more osteotomies.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Transfusion; Ce | 2022 |
Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?
Topics: Adolescent; Aminocaproic Acid; Analysis of Variance; Antifibrinolytic Agents; Blood Loss, Surgical; | 2012 |